Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Mamo, CA
Anthony S. Mamo, Castaic, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100077981 | INTAKE MANIFOLD - Embodiments of the invention are directed to an intake manifold configured to facilitate a greater and smoother flow of air and fuel to the cylinders of an engine and, therefore, to facilitate improved performance of the engine. According to further embodiments, the intake manifold is designed for use with automotive engines. According to particular embodiments, the intake manifold is designed for use in automobiles such as racing automobiles and/or automobiles employing carburetive engines. However, it is understood that embodiments of the invention are configured more generally for use in various automotive applications, including automobiles employing direct-injection engines. | 04-01-2010 |
Shay Mamo, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100096479 | PRESSURE COMPENSATED NON-CLOGGING DRIP EMITTER - A drip emitter that utilizes one or more filters and one or more labyrinths wherein the labyrinth couples the filter(s) to one or more water retainment valves that leads to at least one pool. Prevents clogging by eliminating air into the labyrinth via a water retainment valve that is situated after at least an initial portion of a labyrinth within the drip emitter. Includes non-drain, anti-siphon and ventable versions. Includes a method of two shot injection molding for embodiments of the drip emitter that include non-drain, anti-siphon and ventable variants. | 04-22-2010 |
| 20100244315 | INTERNALLY PRESSURE COMPENSATED NON-CLOGGING DRIP EMITTER - Drip emitter having a pressure compensating element that does not contact the enclosing pipe. First known drip emitter formed from a two-shot injection mold process that includes a deformable element, membrane, compressible element or pressure compensating element that compensates pressure or flow of water against a stiff injection molded surface that is part of the drip emitter body. In addition, this is the first drip emitter (two-shot or otherwise) that includes a compensating surface that is not parallel to the membrane, i.e., at an angle to the plane of the pressure compensating element. May include fluid retainment valve, ventable/anti-siphon/non-drain or other, as part of second injection with second or third material. Allows for simple injection mold construction and eliminates need for ISO conditioning to properly seat the membrane before testing. | 09-30-2010 |
Shay Mamo, La Jolla, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100096478 | NON-CLOGGING NON-PRESSURE COMPENSATED DRIP EMITTER - A non-clogging non-pressure compensated drip emitter that utilizes one or more filters or one or more inwardly offset filters that have an inlet that projects inwardly toward a centerline of the hollow cylindrical emitter body and a labyrinth having only turbulent transfer zones after water enters the labyrinth, wherein the labyrinth couples the filter(s) or inwardly offset filter(s) to the pool. Prevents clogging by eliminating dead transfer zones where sediment can accumulate where no turbulence exists. Also prevents clogging when the filter is positioned downward as the inwardly offset filter rises above any sediment when the emitter is positioned in the field in this downward orientation. Also prevents clogging flat filter configurations that have filters offset radially, i.e., redundant filters per emitter. | 04-22-2010 |
Shumeye Mamo, Oakland, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090143386 | Human adam-10 inhibitors - The present invention provides compounds useful for inhibiting the ADAM-10 protein. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological processes. The present invention also comprises pharmaceutical compositions comprising one or more ADAM-10 inhibitors according to the invention in combination with a pharmaceutically acceptable carrier. Such compositions are useful for the treatment of cancer, arthritis, and diseases related to angiogenesis. Correspondingly, the invention also comprises methods of treating forms of cancer, arthritis, and diseases related to angiogenesis in which ADAM-10 plays a critical role. The invention also provides methods for making bis-aryl ether sulfonyl chlorides and ADAM-10 modulators therefrom. | 06-04-2009 |
| 20100249118 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR - Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. | 09-30-2010 |
| 20100324065 | Compounds and methods for development of Ret Modulators - Compounds active on Ret are described, as well as methods of using such compounds. Also described are crystal structures of Ret surrogates that were determined using X-ray crystallography. The use of such Ret surrogate crystals and structural information can, for example, be used for identifying molecular scaffolds and for developing ligands that bind to and modulate Ret and for identifying improved ligands based on known ligands. | 12-23-2010 |
| 20110059963 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR - Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. | 03-10-2011 |
| 20110092538 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR - Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. | 04-21-2011 |
Shumeye Mamo, Berkeley, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100105953 | Human Adam-10 Inhibitors - The present invention provides compounds useful for inhibiting the ADAM-10 protein, with selectivity versus MMP-1. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological processes. The present invention also comprises pharmaceutical compositions comprising one or more ADAM-10 inhibitors according to the invention in combination with a pharmaceutically acceptable carrier. Such compositions are useful for the treatment of cancer, arthritis, and diseases related to angiogenesis. Correspondingly, the invention also comprises methods of treating forms of cancer, arthritis, and diseases related to angiogenesis in which ADAM-10 plays a critical role. | 04-29-2010 |